Skip to main content
    P

    Pfizer Inc (PFE)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $28.46
    -0.40 (-1.39%)

    Market Cap: $164.67B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Pfizer Inc (PFE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Pfizer (PFE) has a market cap of $164.67B and an enterprise value of $225.52B. Its return on invested capital of 2.69% compares with a 13.48% median across 11 similar companies. Its dividend yield is 6.04%.

    Total Valuation

    Enterprise value is 36.95% above the market cap, as debt exceeds cash.

    Market Cap$164.67B
    Enterprise Value$225.52B
    Latest price (Nov 17, 2026)$28.46

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 6, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Last Ex-Dividend DateNov 6, 2026
    Next Payment DateDec 7, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.02% in the quarter ended Sep 30, 2026 and grew 0.29% a year over 2 years.

    Shares Outstanding5.70B
    Shares Change (YoY)+0.26%
    Shares Change (QoQ)+0.02%
    Share Count Growth (2Y CAGR)+0.29%

    Valuation Ratios

    Sales and book value multiples are 2.5x and 1.8x. Its year-end P/E ranged from 7.7x to 15.7x from 2016 to 2025.

    P/E Ratio9.3x
    Forward P/E9.2x
    P/S Ratio2.5x
    Forward P/S2.6x
    P/B Ratio1.8x
    P/FCF Ratio13.8x
    P/OCF Ratio11.6x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 20.7x EBITDA and 18.9x free cash flow.

    EV / Earnings55.4x
    EV / Sales3.5x
    EV / EBITDA20.7x
    EV / EBIT52.9x
    EV / FCF18.9x

    Price Statistics

    The stock is up 15.47% over 52 weeks and trades 0.04% below its 50-day average.

    Beta (1Y)0.29
    52-Week Change+15.47%
    1-Month Change-1.91%
    3-Month Change+2.25%
    6-Month Change+12.86%
    5-Year Change-30.22%
    10-Year Change-3.75%
    Total Return (1Y)+22.45%
    Total Return (3Y CAGR)+2.08%
    Total Return (5Y CAGR)-7.74%
    Return vs SPY (1Y)+2.14%
    Max Drawdown (1Y)-16.92%
    Max Drawdown (3Y)-28.99%
    Sharpe Ratio (1Y)0.61
    Correlation with SPY (1Y)0.19
    50-Day Average$28.47
    200-Day Average$26.45
    52-Week Range$22.76 to $30.99
    RSI (14 Days)43.1
    Average Volume (20 Days)36.23M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.42x current liabilities, and total debt is 0.70x shareholder equity.

    Current Ratio1.42x
    Quick Ratio1.10x
    Debt / Equity0.70x
    Debt / EBITDA5.82x
    Debt / FCF5.32x

    Returns and Efficiency

    Return on invested capital is 2.69% over the last 12 months, against a 5-year average of 10.84%.

    Return on Equity (ROE)4.58%
    Return on Assets (ROA)1.99%
    Return on Invested Capital (ROIC)2.69%
    Return on Capital Employed (ROCE)2.47%
    ROE (5Y Average)16.39%
    ROA (5Y Average)7.31%
    ROIC (5Y Average)10.84%
    Asset Turnover0.31x
    Inventory Turnover1.70x
    Receivables Turnover4.77x
    Cash Conversion Cycle198 days

    Taxes

    Income tax took 4.37% of pretax income over the last 12 months.

    Income Tax (TTM)$186.00M
    Effective Tax Rate4.37%

    Scores

    PFE has an Altman Z-Score of 2.09, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score2.09
    Altman Z ZoneGrey
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $63.63B over the last 12 months is up 1.34% from the 12 months before.

    Revenue$63.63B
    Revenue Growth (YoY)+1.34%
    Gross Profit$46.69B
    Operating Income$13.64B
    Pretax Income$4.26B
    Net Income$4.07B
    EBIT$4.26B
    Reported EPS (TTM)$3.05

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 43.51% of the $204.54B in total assets.

    Cash and Equivalents$1.82B
    Total Debt$62.67B
    Net Debt$60.85B
    Net Debt Per Share$10.67
    Working Capital$13.28B
    Shareholder Equity$89.00B
    Book Value Per Share$15.61
    Tangible Book Value-$28.42B
    Total Assets$204.54B
    Total Liabilities$115.24B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.39B of capital spending, operating cash flow left $11.79B of free cash flow.

    Operating Cash Flow$14.17B
    Capital Expenditures$2.39B
    Free Cash Flow$11.79B
    FCF Per Share$2.07
    Depreciation and Amortization$6.50B
    Dividends Paid$9.79B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 21.44%, against a 5-year average of 20.74%.

    Gross Margin73.38%
    Operating Margin21.44%
    Pretax Margin6.69%
    Net Margin6.40%
    EBIT Margin6.70%
    FCF Margin18.52%
    Gross Margin (5Y Average)66.50%
    Operating Margin (5Y Average)20.74%
    Net Margin (5Y Average)17.38%

    Growth

    Revenue fell 14.80% a year over 3 years, and EPS 21.12% a year.

    Revenue Growth (3Y CAGR)-14.80%
    Revenue Growth (5Y CAGR)+8.48%
    EPS Growth (3Y CAGR)-21.12%
    EPS Growth (5Y CAGR)+3.50%
    FCF Growth (3Y CAGR)-29.62%
    FCF Growth (5Y CAGR)-5.71%
    Operating Income Growth (3Y CAGR)-26.44%
    Book Value Per Share Growth (2Y CAGR)-1.77%

    Revenue and profit by year

    Dividends and Yields

    PFE pays out 69.17% of earnings as dividends.

    Dividend Per Share (Annual)$1.72
    Dividend Yield6.04%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+2.44%
    Dividend Growth (5Y CAGR)+2.50%
    Payout Ratio69.17%
    FCF Payout Ratio83.08%
    Earnings Yield10.75%
    FCF Yield7.27%
    Shareholder Yield6.04%

    Full dividend history

    Stock Splits

    The last split was a 3-for-1 forward split on Jul 1, 1999.

    Last Split DateJul 1, 1999
    Split TypeForward split
    Split Ratio3:1

    Peer Position

    Against 9 similar companies, PFE has the lowest P/E.

    P/E Ratio9.3x vs 21.3x median
    P/S Ratio2.5x vs 4.9x median
    ROIC2.69% vs 13.48% median
    Revenue Growth (Trailing 4 Quarters, YoY)+1.34% vs +6.13% median
    Dividend Yield6.04% vs 2.37% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -1.41% and EPS growth at -4.46% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-1.41%
    EPS Growth Forecast (2Y CAGR)-4.46%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PFE

    What is PFE's market cap?

    Pfizer has a market cap of $164.67B. Its enterprise value, which adds debt and subtracts cash, is $225.52B.

    What is PFE's P/E ratio?

    Pfizer has a trailing P/E ratio of 9.3x and a forward P/E of 9.2x.

    How many shares of PFE are outstanding?

    Pfizer has 5.70B shares outstanding. The count is up 0.26% from a year earlier.

    Does PFE pay a dividend?

    Yes. Pfizer pays $1.72 a share a year, a dividend yield of 6.04%.

    How much debt does PFE have?

    Pfizer has $62.67B of total debt and $1.82B of cash and equivalents, a net debt position of $60.85B.